Gilgamesh Pharmaceuticals

Gilgamesh Pharmaceuticals YC 申请

Summer 2020Active

Gilgamesh Pharmaceuticals 在 Summer 2020 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是:公司做什么、谁创立了它,以及其 YC 申请,按照真实 YC 表格逐题重建。

YC 批次
Summer 2020
行业
HealthcareDrug Discovery and Delivery
团队规模
15
状态
Active
已发布
2020

创始人

  • JONATHAN SPORN
    JONATHAN SPORNFounder
  • Andrew Kruegel
    Andrew KruegelFounder
  • Dalibor Sames
    Dalibor SamesFounder

Gilgamesh Pharmaceuticals 做什么

Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise. We are an experienced team, with proven success in biotech exits and inventions.

Gilgamesh Pharmaceuticals 的 YC 申请,重建版

Y Combinator 申请

Gilgamesh Pharmaceuticals,Summer 2020 期。来自公开数据的真实申请问题解答。

  1. Founders2
  2. Company7
  3. Progress7
  4. Idea4
  5. Equity3
  6. Curious2
  7. Batch Preference1

Company

Company name

Gilgamesh Pharmaceuticals

Describe what your company does in 50 characters or less.

Developing novel psychedelic-based mental health drugs

What is your company going to make? Please describe your product and what it does or will do.

We develop new chemical entities for mental health conditions using medicinal chemistry and neuroscience. Our focus is on creating safer, more effective psychedelic drugs that can be clinically approved to treat disorders like depression and PTSD. This involves designing molecules, securing IP, and advancing them through clinical trials.

Where do you live now, and where would the company be based after YC?

We are based in New York, NY, with remote team members. Post-YC, we would remain headquartered in New York.

Explain your decision regarding location.

New York is where our team and operational setup are located. The biotech and mental health ecosystem here enriches our access to talent and clinical partners. We don't plan to relocate because it suits our scientific and business needs.

21 更多回答 在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开,紧邻每个其他 YC 批次。

常见问题解答

这是 Gilgamesh Pharmaceuticals 的真实 YC 申请吗?

不是。Y Combinator 对提交的申请保密。这是重建版:使用 Gilgamesh Pharmaceuticals 的公开数据(发布笔记、创始人背景、产品描述)回答真实的 YC 表格问题。它展示了像 Gilgamesh Pharmaceuticals 这样的公司会如何向 YC 自我介绍,而不是他们提交的文本。

Gilgamesh Pharmaceuticals 是哪个 YC 批次的?

Gilgamesh Pharmaceuticals 是 Y Combinator Summer 2020 批次的成员。

谁创立了 Gilgamesh Pharmaceuticals?

Gilgamesh Pharmaceuticals 由 JONATHAN SPORN, Andrew Kruegel, Dalibor Sames 创立。

Gilgamesh Pharmaceuticals 做什么?

Gilgamesh Pharmaceuticals, a Clinical stage biotechnology company…

如何阅读完整的重建申请?

创建免费的 Round Funded 账户。YC Insights 中包含 Gilgamesh Pharmaceuticals 的完整 26 个问题的版本,以及其他所有 YC 批次的公司信息。

更多 YC 初创公司,例如 Gilgamesh Pharmaceuticals